Epilepsy Study Consortium Inc

Disease-specific health organization based in Reston, VA. 7 employees. Exempt under §501(c)(3).

MissionACCELERATING THE DEVELOPMENT OF NEW THERAPIES IN EPILEPSY TO IMPROVE PATIENT CARE THROUGH RESEARCH.

EIN
20-4950952
State
VA
Sector
Disease-specific health
Budget band
$1M–$2.5M
Latest filing
TY 2024
Records
3 officers · 6 years

Financial snapshot · TY 2024

$2.5M
Total revenue
$2.2M
Total expenses
$3.7M
Net assets

Financial health · TY 2024

94
Strong financial health
Composite score out of 100 based on reserve ratio, program efficiency, and revenue diversification.
Reserve ratio
100
20.1 months of expenses
Program efficiency
100
98.4% spent on programs
Revenue diversity
71
Mix of program fees, grants & contributions

Leadership compensation

Bree Diventura
CO-EXECUTIVE DIRECTOR
$240,536
93th percentile vs. peers
Meryl J Lozano
CO-EXECUTIVE DIRECTOR
$150,417
93th percentile vs. peers
$110,004
60th percentile vs. peers

Is this your organization?

Claim this page for a private dashboard with financial health, peer benchmarks, and comp history.

Claim this page
Epilepsy Study Consortium Inc Executive Compensation | 990 Data | DoubleNine